Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial. Read more about Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. Read more about Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. Read more about Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study. Read more about Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts. Read more about Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Read more about Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. Read more about Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.
Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation. Read more about Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation.
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia. Read more about The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. Read more about Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
